Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Dow
Boehringer Ingelheim
Johnson and Johnson
Moodys
UBS
AstraZeneca
Julphar
Fuji

Generated: April 26, 2018

DrugPatentWatch Database Preview

CHLORPROMAZINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Chlorpromazine Hydrochloride, and what generic alternatives are available?

Chlorpromazine Hydrochloride is a drug marketed by Actavis Mid Atlantic, Pharm Assoc, Wockhardt, Abraxis Pharm, Marsam Pharms Llc, Watson Labs, West-ward Pharms Int, Wyeth Ayerst, Alpharma Us Pharms, Abbott, Cycle Pharms Ltd, Ivax Sub Teva Pharms, Kv Pharm, Lederle, Purepac Pharm, Pvt Form, Sandoz, Usl Pharma, Vangard, and West Ward. and is included in fifty-four NDAs.

The generic ingredient in CHLORPROMAZINE HYDROCHLORIDE is chlorpromazine hydrochloride. There are twenty drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the chlorpromazine hydrochloride profile page.
Drug patent expirations by year for CHLORPROMAZINE HYDROCHLORIDE
Pharmacology for CHLORPROMAZINE HYDROCHLORIDE
Ingredient-typePhenothiazines
Drug ClassPhenothiazine

US Patents and Regulatory Information for CHLORPROMAZINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Purepac Pharm CHLORPROMAZINE HYDROCHLORIDE chlorpromazine hydrochloride TABLET;ORAL 080403-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Kv Pharm CHLORPROMAZINE HYDROCHLORIDE chlorpromazine hydrochloride TABLET;ORAL 085748-002 Jan 4, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sandoz CHLORPROMAZINE HYDROCHLORIDE chlorpromazine hydrochloride TABLET;ORAL 080439-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs CHLORPROMAZINE HYDROCHLORIDE chlorpromazine hydrochloride TABLET;ORAL 085956-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Medtronic
Healthtrust
Cantor Fitzgerald
Dow
Queensland Health
Accenture
Citi
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.